Adagio Competitors
| ADGM Stock | 1.01 0.02 2.02% |
Adagio Medical vs Vivos Therapeutics Correlation
Very good diversification
The correlation between Adagio Medical Holdings and VVOS is -0.43 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adagio Medical Holdings and VVOS in the same portfolio, assuming nothing else is changed.
Moving against Adagio Stock
| 0.5 | MMM | 3M Company | PairCorr |
| 0.35 | PSGTF | PT Semen Indonesia | PairCorr |
| 0.32 | VLCN | Volcon Inc Symbol Change | PairCorr |
| 0.31 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.31 | MSFT | Microsoft Sell-off Trend | PairCorr |
Adagio Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Adagio Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Adagio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Adagio Medical Holdings does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adagio Stock performing well and Adagio Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adagio Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| COCH | 3.46 | (0.89) | 0.00 | (1.09) | 0.00 | 6.06 | 29.78 | |||
| ALUR | 5.94 | (0.63) | 0.00 | (0.09) | 0.00 | 16.54 | 40.95 | |||
| CTXR | 4.62 | (0.79) | 0.00 | (0.26) | 0.00 | 10.59 | 38.23 | |||
| NVNO | 5.66 | (1.29) | 0.00 | (0.44) | 0.00 | 8.99 | 41.30 | |||
| CODX | 5.94 | (1.80) | 0.00 | (0.80) | 0.00 | 9.88 | 75.41 | |||
| ATHA | 4.12 | 0.59 | 0.10 | (0.62) | 4.10 | 6.70 | 71.83 | |||
| IRIX | 3.49 | 0.51 | 0.10 | 0.52 | 4.63 | 7.89 | 35.45 | |||
| LPTX | 14.85 | 6.59 | 0.63 | 50.80 | 6.90 | 25.00 | 65.13 | |||
| VSEE | 4.02 | (1.51) | 0.00 | 10.04 | 0.00 | 5.71 | 20.66 | |||
| VVOS | 3.41 | (0.52) | 0.00 | (0.36) | 0.00 | 7.18 | 31.84 |
Cross Equities Net Income Analysis
Compare Adagio Medical Holdings and related stocks such as Envoy Medical, Allurion Technologies, and Citius Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COCH | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (8.7 M) | (15.9 M) | (29.9 M) | (20.8 M) | (18.7 M) | (19.7 M) |
| ALUR | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (12.4 M) | (37.7 M) | (80.6 M) | (26.1 M) | (23.5 M) | (24.7 M) |
| CTXR | (26.3 K) | (22 K) | (31.4 K) | (1.3 M) | (2.9 M) | (8.3 M) | (10.4 M) | (12.5 M) | (15.6 M) | (17.5 M) | (23.1 M) | (33.6 M) | (32.5 M) | (39.1 M) | (37.4 M) | (33.7 M) | (32 M) |
| NVNO | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.6 M) | (5.9 M) | (7.8 M) | (13 M) | (7.6 M) | (9.1 M) | (16.5 M) | (24.7 M) | (23.5 M) | (21.8 M) | (19.6 M) | (18.7 M) |
| CODX | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (2 M) | (1.9 M) | (7 M) | (6.3 M) | (6.2 M) | 42.5 M | 36.7 M | (14.2 M) | (35.3 M) | (37.6 M) | (33.9 M) | (32.2 M) |
| IRIX | 1000 K | 2.6 M | 1.4 M | 2.2 M | 10 M | 474 K | (11.7 M) | (12.9 M) | (12.8 M) | (8.8 M) | (6.3 M) | (5.2 M) | (7.5 M) | (9.6 M) | (8.9 M) | (8 M) | (7.6 M) |
| VSEE | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 258.9 K | 475.9 K | (836.2 K) | (3.8 M) | (57.7 M) | (51.9 M) | (49.3 M) |
| VVOS | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (10.8 M) | (12.1 M) | (20.3 M) | (23.8 M) | (13.6 M) | (11.1 M) | (10 M) | (10.5 M) |
Adagio Medical Holdings and related stocks such as Envoy Medical, Allurion Technologies, and Citius Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Adagio Medical Holdings financial statement analysis. It represents the amount of money remaining after all of Adagio Medical Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Adagio Medical Competitive Analysis
The better you understand Adagio Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Adagio Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Adagio Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Adagio Medical Competition Performance Charts
Five steps to successful analysis of Adagio Medical Competition
Adagio Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Adagio Medical Holdings in relation to its competition. Adagio Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Adagio Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Adagio Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Adagio Medical Holdings, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Adagio Medical position
In addition to having Adagio Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Adagio Medical Correlation with its peers. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Pharmaceuticals sector continue expanding? Could Adagio diversify its offerings? Factors like these will boost the valuation of Adagio Medical. If investors know Adagio will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Adagio Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.24) | Revenue Per Share | Quarterly Revenue Growth 0.756 | Return On Assets | Return On Equity |
Investors evaluate Adagio Medical Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Adagio Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Adagio Medical's market price to deviate significantly from intrinsic value.
Understanding that Adagio Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adagio Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Adagio Medical's market price signifies the transaction level at which participants voluntarily complete trades.